News on research and diagnostics for metabolic disorders and metabolic diseases.
The company is offering introductory pricing on Helix services for heart health and weight loss, and has shifted its flagship program from a yearly subscription to a monthly option.
With exome and/or RNA sequences for dozens of insulinomas, researchers saw epigenetic, development, and other pathways prompting insulin-producing cell expansion.
The researchers believe that the discovery of the genetic loci linked to T2D and CHD will lead to therapeutic opportunities to lower the risk of both diseases.
The new company will develop microbiome diagnostics for multiple indications including inflammatory bowel disease and liver disorders.
The researchers noted that 93 of the newly identified loci are found in both African-American and European populations, and only 18 are European-specific.
